Envestnet Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $564K | Sell |
11,949
-2,276
| -16% | -$107K | ﹤0.01% | 3612 |
|
|
2025
Q1 | $556K | Buy |
14,225
+5,254
| +59% | +$205K | ﹤0.01% | 3559 |
|
|
2024
Q4 | $486K | Sell |
8,971
-193
| -2% | -$10.5K | ﹤0.01% | 3601 |
|
|
2024
Q3 | $462K | Buy |
9,164
+1,018
| +12% | +$51.3K | ﹤0.01% | 3577 |
|
|
2024
Q2 | $358K | Sell |
8,146
-296
| -4% | -$13K | ﹤0.01% | 3630 |
|
|
2024
Q1 | $424K | Sell |
8,442
-675
| -7% | -$33.9K | ﹤0.01% | 3546 |
|
|
2023
Q4 | $551K | Sell |
9,117
-9,411
| -51% | -$568K | ﹤0.01% | 3277 |
|
|
2023
Q3 | $1.06M | Buy |
18,528
+13,430
| +263% | +$766K | ﹤0.01% | 2773 |
|
|
2023
Q2 | $260K | Buy |
+5,098
| New | +$260K | ﹤0.01% | 3557 |
|